Revolution Medicines, Inc. (RVMD) has 22 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 13 sales totalling $57.8M. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 16, 2026 | Mancini Anthony See Remarks | −$353,449 | 1,774 | −4% | Yes | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | Sandler Alan B. Chief Development Officer | −$67,941 | 341 | −1% | Yes | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | Horn Margaret A Chief Operating Officer | −$989,613 | 4,967 | −3% | Yes | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | Kelsey Stephen Michael See Remarks | −$1,109,554 | 5,569 | −2% | Yes | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | GOLDSMITH MARK A See Remarks | −$2,786,938 | 13,988 | −5% | Yes | |
|
|
||||||
Showing the 5 most recent of 22 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free